vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and UL Solutions Inc. (ULS). Click either name above to swap in a different company.
UL Solutions Inc. is the larger business by last-quarter revenue ($340.0M vs $185.2M, roughly 1.8× AMICUS THERAPEUTICS, INC.). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -12.4%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -31.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
The UL enterprise is a global private safety company headquartered in Northbrook, Illinois, composed of three organizations, UL Research Institutes, UL Standards & Engagement and UL Solutions.
FOLD vs ULS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $340.0M |
| Net Profit | $1.7M | — |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 24.4% |
| Net Margin | 0.9% | — |
| Revenue YoY | 23.7% | -12.4% |
| Net Profit YoY | -88.5% | — |
| EPS (diluted) | $0.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $340.0M | ||
| Q4 25 | $185.2M | $789.0M | ||
| Q3 25 | $169.1M | $783.0M | ||
| Q2 25 | $154.7M | $776.0M | ||
| Q1 25 | $125.2M | $705.0M | ||
| Q4 24 | $149.7M | $739.0M | ||
| Q3 24 | $141.5M | $731.0M | ||
| Q2 24 | $126.7M | $730.0M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7M | $67.0M | ||
| Q3 25 | $17.3M | $100.0M | ||
| Q2 25 | $-24.4M | $91.0M | ||
| Q1 25 | $-21.7M | $67.0M | ||
| Q4 24 | $14.7M | $81.0M | ||
| Q3 24 | $-6.7M | $88.0M | ||
| Q2 24 | $-15.7M | $101.0M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | 49.7% | ||
| Q3 25 | 88.5% | 50.3% | ||
| Q2 25 | 90.2% | 49.4% | ||
| Q1 25 | 90.7% | 48.4% | ||
| Q4 24 | 90.1% | 47.4% | ||
| Q3 24 | 90.6% | 49.0% | ||
| Q2 24 | 91.1% | 50.1% |
| Q1 26 | — | 24.4% | ||
| Q4 25 | 8.6% | 15.0% | ||
| Q3 25 | 20.3% | 19.9% | ||
| Q2 25 | -6.1% | 17.9% | ||
| Q1 25 | -6.3% | 15.5% | ||
| Q4 24 | 10.7% | 15.6% | ||
| Q3 24 | 15.3% | 17.8% | ||
| Q2 24 | 11.8% | 17.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 8.5% | ||
| Q3 25 | 10.2% | 12.8% | ||
| Q2 25 | -15.8% | 11.7% | ||
| Q1 25 | -17.3% | 9.5% | ||
| Q4 24 | 9.8% | 11.0% | ||
| Q3 24 | -4.8% | 12.0% | ||
| Q2 24 | -12.4% | 13.8% |
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.33 | ||
| Q3 25 | $0.06 | $0.49 | ||
| Q2 25 | $-0.08 | $0.45 | ||
| Q1 25 | $-0.07 | $0.33 | ||
| Q4 24 | $0.05 | $0.40 | ||
| Q3 24 | $-0.02 | $0.44 | ||
| Q2 24 | $-0.05 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | — |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | — |
| Total Assets | $949.9M | — |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $293.5M | $295.0M | ||
| Q3 25 | $263.8M | $255.0M | ||
| Q2 25 | $231.0M | $272.0M | ||
| Q1 25 | $250.6M | $267.0M | ||
| Q4 24 | $249.9M | $298.0M | ||
| Q3 24 | $249.8M | $327.0M | ||
| Q2 24 | $260.1M | $295.0M |
| Q1 26 | — | — | ||
| Q4 25 | $392.7M | $491.0M | ||
| Q3 25 | $392.0M | $544.0M | ||
| Q2 25 | $391.3M | $608.0M | ||
| Q1 25 | $390.7M | $653.0M | ||
| Q4 24 | $390.1M | $742.0M | ||
| Q3 24 | $389.5M | $797.0M | ||
| Q2 24 | $388.9M | $810.0M |
| Q1 26 | — | — | ||
| Q4 25 | $274.2M | $1.3B | ||
| Q3 25 | $230.4M | $1.2B | ||
| Q2 25 | $204.3M | $1.1B | ||
| Q1 25 | $193.6M | $970.0M | ||
| Q4 24 | $194.0M | $904.0M | ||
| Q3 24 | $178.8M | $872.0M | ||
| Q2 24 | $132.5M | $769.0M |
| Q1 26 | — | — | ||
| Q4 25 | $949.9M | $2.9B | ||
| Q3 25 | $868.8M | $2.9B | ||
| Q2 25 | $815.3M | $2.9B | ||
| Q1 25 | $789.8M | $2.9B | ||
| Q4 24 | $785.0M | $2.8B | ||
| Q3 24 | $786.6M | $2.9B | ||
| Q2 24 | $749.5M | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | 0.39× | ||
| Q3 25 | 1.70× | 0.46× | ||
| Q2 25 | 1.92× | 0.56× | ||
| Q1 25 | 2.02× | 0.67× | ||
| Q4 24 | 2.01× | 0.82× | ||
| Q3 24 | 2.18× | 0.91× | ||
| Q2 24 | 2.93× | 1.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $144.0M | ||
| Q3 25 | $35.7M | $155.0M | ||
| Q2 25 | $-26.5M | $147.0M | ||
| Q1 25 | $7.8M | $154.0M | ||
| Q4 24 | $-3.9M | $130.0M | ||
| Q3 24 | $-23.0M | $150.0M | ||
| Q2 24 | $22.7M | $103.0M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $86.0M | ||
| Q3 25 | $35.3M | $109.0M | ||
| Q2 25 | $-28.9M | $105.0M | ||
| Q1 25 | $7.5M | $103.0M | ||
| Q4 24 | $-4.2M | $72.0M | ||
| Q3 24 | $-23.3M | $84.0M | ||
| Q2 24 | $21.6M | $47.0M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 10.9% | ||
| Q3 25 | 20.9% | 13.9% | ||
| Q2 25 | -18.7% | 13.5% | ||
| Q1 25 | 6.0% | 14.6% | ||
| Q4 24 | -2.8% | 9.7% | ||
| Q3 24 | -16.5% | 11.5% | ||
| Q2 24 | 17.0% | 6.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 7.4% | ||
| Q3 25 | 0.2% | 5.9% | ||
| Q2 25 | 1.6% | 5.4% | ||
| Q1 25 | 0.2% | 7.2% | ||
| Q4 24 | 0.2% | 7.8% | ||
| Q3 24 | 0.3% | 9.0% | ||
| Q2 24 | 0.9% | 7.7% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | 2.15× | ||
| Q3 25 | 2.06× | 1.55× | ||
| Q2 25 | — | 1.62× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | -0.27× | 1.60× | ||
| Q3 24 | — | 1.70× | ||
| Q2 24 | — | 1.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
ULS
Segment breakdown not available.
